Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 28, 2021

View Archived Issues

New method for nitroimidazole fluoroalkylation through a visible-light-prompted radical reaction

ScinnoHub Pharmaceutical divulges inhibitors of RET, Src and BTK

New GLP-1 receptor agonists described by Medshine Discovery, Hangzhou Sciwind Biosciences

Shanghai Antengene discovers GTPase KRAS inhibitors

Chengdu Kanghong Pharmaceutical patents thyroid hormone receptor agonists

BeiGene presents new IAP protein inhibitors

Novel anti-CD19 CAR binds to a membrane-proximal domain of CD19 for treatment of B-cell malignancies

MPI-8 selectively inhibits both SARS-CoV-2 MPro and the host cathepsin L

Blocking phosphoglycerate dehydrogenase can reduce lymphoma progression

TMTP1 peptide dimer probe shows promise for tumor imaging and imaging-guided photothermal therapy

Searching for novel tricyclic M4 PAM scaffolds with improved pharmacological properties

Icaritin derivatives as potential DEPTOR inhibitors against multiple myeloma

Monoclonal antibodies can't keep Omicron variant in check

WuXi Biologics and ImmuneOncia to jointly develop PD-L1/CD47 bispecific antibody

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...